Showing results (61-70 of 696) with videos related to

Sort By:
Pageof 70
Blood|March 31, 2012
CLL and deletion 13q14: merely the miRs?Daniel Mertens, Stephan Stilgenbauer
Oncotarget|February 15, 2011
Refractory chronic lymphocytic leukemia--new therapeutic strategiesAndrea Schnaiter, Stephan Stilgenbauer
Therapeutic Advances in Hematology|April 5, 2013
Novel targeted treatment strategies for refractory chronic lymphocytic leukaemiaAndrea Schnaiter, Stephan Stilgenbauer
Hematology/Oncology Clinics of North America|April 9, 2013
17p deletion in chronic lymphocytic leukemia: risk stratification and therapeutic approachAndrea Schnaiter, Stephan Stilgenbauer
Blood|October 23, 2008
miR-34a as part of the resistance network in chronic lymphocytic leukemiaThorsten Zenz, Julia Mohr, Eric Eldering, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
TP53 mutation and survival in chronic lymphocytic leukemiaThorsten Zenz, Barbara Eichhorst, Raymonde Busch, et al.
Blood|December 18, 2012
Telomere length in mantle cell lymphomaBilly Michael Chelliah Jebaraj, Dirk Kienle, André Lechel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 18, 2008
First demonstration of leukemia imaging with the proliferation marker 18F-fluorodeoxythymidineAndreas K Buck, Martin Bommer, Malik E Juweid, et al.
Blood|December 5, 2018
FBXW7 mutations reduce binding of NOTCH1, leading to cleaved NOTCH1 accumulation and target gene activation in CLLViola Close, William Close, Sabrina Julia Kugler, et al.
Pageof 70